J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...
SurvivorNet on MSN

ASCO 2026: A major prostate cancer trial shows drug can keep high-risk disease from returning for longer

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...
Daily Mail on MSN

Hope for thousands as new drug cuts prostate cancer relapse risk by a third

Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...
AOL

New prostate cancer drug showing ‘remarkable’ results during clinical trial

Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts. This innovative treatment, an immunotherapy designed to harness the ...
STAT

For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...
Fred Hutch

Chemotherapy for Prostate Cancer

Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment which means the medicines will travel ...

J&J drug Erleada reduces risk of prostate cancer spread, death

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...